CHINA SHINEWY P News

Huaxing Securities: Reiterates a "buy" rating on Shineway Pharm (02877), with target price revised down to 18 Hong Kong dollars.

Zhitong FinanceSep 4 15:03

Shenwei Pharmaceutical (2877.HK): Traditional Chinese medicine cash cow with predictable performance and high dividend rate

Jul 2 00:00

Shenwei Pharmaceutical (2877.HK): Rapid growth in performance, smooth progress in research and development of new drugs

Mar 28 00:00

CCB International: Maintaining Shenwei Pharmaceutical (02877)'s “Outperforming Market” Rating, Target Price Reduced to HK$9.5

Zhitong FinanceNov 13, 2023 11:09

Research Report Nuggets | China Merchants Securities: The target price for the first “increase in holdings” rating for Shenwei Pharmaceutical is HK$13.8

Gelonghui FinanceAug 3, 2023 09:10

Changes in Hong Kong stocks | Shenwei Pharmaceutical (02877) rose by more than 7% and is expected to increase profits by at least 25% year-on-year last year, Daimo raised its earnings estimates and target prices

Zhitong FinanceMar 7, 2023 10:30

Changes in Hong Kong stocks | Shenwei Pharmaceutical rose 2 days in a row after making a profit, raised target prices and tested profit

Gelonghui FinanceMar 7, 2023 10:12

Big Bank Ratings | Morgan Stanley: Raising the target price of Shenwei Pharmaceutical to HK$7.8 to maintain the same rating as the market

Gelonghui FinanceMar 6, 2023 12:41

Jefferies: Upgraded the rating of Shenwei Pharmaceutical (02877) to “buy” target price by 59% to HK$14

Zhitong FinanceNov 16, 2022 17:05

Shenwei Pharmaceutical (02877.HK): Chinese medicine formulations are growing rapidly, and companies have abundant cash flow

國元國際Nov 26, 2020 00:00

Shenwei Pharmaceutical (2877.HK): Growth is expected to resume in the second quarter

招銀國際Aug 1, 2019 00:00

Shenwei Pharmaceutical (2877.HK): Sales are expected to slow in the fourth quarter of '18

招銀國際Feb 1, 2019 00:00

SHENWEI PHARMACEUTICAL (2877.HK): Reverse Roadshow Summary; Formulated Particles Are the Main Growth Engine

銀河國際Nov 9, 2018 00:00

Shenwei Pharmaceutical (2877.HK): summary of reverse roadshow in Shijiazhuang

招銀國際Oct 31, 2018 00:00

Shenwei Pharmaceutical (2877.HK): sustained recovery in the second quarter valuation attracts

招銀國際Sep 3, 2018 00:00

Shenwei Pharmaceutical (2877.HK): strong performance in the first quarter confirms the trend of recovery

招銀國際Apr 27, 2018 00:00

Shenwei Pharmaceutical (2877.HK): strong recovery momentum

招銀國際Apr 4, 2018 00:00

Shenwei Pharmaceutical (2877.HK): performance is back on track

招銀國際Feb 23, 2018 00:00

Shenwei Pharmaceutical (2877.HK): reappearance of Dawn

招銀國際Jan 17, 2018 00:00

神威药业(2877.HK)季报点评：第三季业绩仍然疲弱 维持「沽出」评级

交銀國際Nov 2, 2016 00:00